Zydus’ Desidustat efficacious in treating hypoxia in Mexico’s hospitalised COVID-19 patients:…
None of the hospitalised patients required mechanical ventilator in the Desidustat arm, while 25 per cent patients on the standard…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
ARDS
Zydus Cadila files IND application for ZYIL1, NLRP3 inflammasome inhibitor
It can selectively modulate the inflammatory responses caused by the ‘Cytokine Storm’ in ARDS, COVID19 and other inflammatory…
USFDA approves IND application from Reven Pharma for Rejuveinix to treat COVID-19
RJX is an IV formulation being developed for treatment of inflammatory disorders, including COVID-19 patients with viral sepsis,…
USPTO grants patent to Tiziana for fully human monoclonal antibody, TZLS-501
The grant of this additional patent on TZLS-501 is of significance for the potential treatment of COVID-19 and other pulmonary…
Anti-TNF therapies could treat patients with COVID-19-related ARDS
This would reduce COVID-19 mortality, as about 17 of COVID-19 patients develop ARDS, states GlobalData
Shiv Nadar University develops molecule with potential to cure COVID-19
The molecule has the potential to be developed into a drug that can cure Acute Respiratory Distress Syndrome (ARDS) in COVID-19…